How does bone recover in patients with tumor-induced osteomalacia? Long-term follow-up in a national cohort study
María Belén Zanchetta(Universidad del Salvador), José Zanchetta(Universidad del Salvador), Giselle Mumbach(Sociedad Española de Cardiología), Analía Pignatta(National University of Catamarca), Erich Fradinger(Universidad del Salvador), Carolina Fux Otta(Universidad Nacional de Córdoba), Walter Douthat, Carlos Vigovich(Euro-Centrum), Luisa Plantalech, Fernando Jerkovich(Universidad del Salvador), María Bastianello(Fundación Universitaria San Pablo CEU), P Tartaglia(Hospital Privado), Juan Manuel Roganovich, María Celeste Balonga(Universidad del Salvador), Natalia Elías(Hospital Británico de Buenos Aires), Yamile Mocarbel(Universidad de Buenos Aires), Ana Carolina Cohen(Centro Científico Tecnológico - Tucumán), Griselda Cecchi(Hospital Universitario Austral), Florencia Scioscia(Universidad del Salvador), José Luis Mansur(Bone Health and Osteoporosis Foundation)
Cited by 1
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k